Migraine treatment also appears effective for cluster headachesSeptember 12, 2006Zolmitriptan nasal spray, used to treat migraine headaches, also may be safe and effective in treating painful cluster headaches, according to an article posted online today that will appear in the November 2006 print issue of Archives of Neurology, one of the JAMA/Archives journals. Cluster headaches are characterized by attacks of excruciating pain that typically involve one side of the head and last between 15 and 180 minutes, according to background information in the article. Because the pain is so severe, rapid and effective treatments are needed. Medications known as triptans are typically used to treat migraines; some, including sumatriptan and oral zolmitriptan, have been shown to be effective for cluster headaches as well. Zolmitriptan nasal spray is a new formulation that is absorbed through the nasal passages and acts more quickly. One preliminary study has suggested that the medication could be effective for cluster headache. Elizabeth Cittadini, M.D., The National Hospital for Neurology and Neurosurgery, Queen Square, London, and colleagues evaulated the use of the nasal spray in 92 patients (80 men, 12 women, average age 40 years) with cluster headaches. Without treatment, the patients' headaches lasted at least 45 minutes. Over the course of the study, the participants each treated three headache attacks: one with placebo, one with 5 milligrams of zolmitriptan nasal spray and one with 10 milligrams of zolmitriptan nasal spray, in random order. Patients were assessed at five, ten, 15 and 30 minutes after taking the medication. If their headache did not subside at 30 minutes, they were allowed to take a different drug to relieve pain. Because some patients dropped out of the study or did not have enough headaches during the study period, 69 patients were included in the final analysis, which was based on 65 attacks treated with 5 milligrams of zolmitriptan nasal spray, 63 attacks treated with a 10-milligram dose and 61 attacks treated with placebo. Patients reported headache relief after 30 minutes in 38 (61 percent) of the attacks treated with the 10-milligram dose, 27 (42 percent) of those treated with the 5-milligram dose and 14 (23 percent) of those treated with placebo. Thirty-one patients (50 percent) taking 10 milligrams of the nasal spray were pain-free at 30 minutes, compared with 18 (28 percent) of those taking the 5-milligram dose and 10 (16 percent) who took placebo. Although one patient dropped out of the study due to adverse effects-including shortness of breath, vomiting and joint or muscle stiffness-no serious side effects were reported. "The very minimal dropout rate and low number of adverse events reported suggest that intranasal zolmitriptan is well tolerated in patients treating acute cluster headaches," the authors write. "The data provide evidence that zolmitriptan nasal spray can be used as a first-line abortive therapy, along with sumatriptan nasal spray or inhaled oxygen, in the management of cluster headaches," they conclude. JAMA and Archives Journals |
|||||||||||||||||||||
| Related Headaches Current Events and Headaches News Articles Increased stroke risk from birth control pills She was only 30 years old, but she was experiencing the classic symptoms of a stroke. Her speech suddenly became slurred, and her left hand became clumsy while eating. Surgery potentially best option for severe migraine headaches The disability from migraine headaches is an enormous health burden affecting over 30 million Americans. Migraine sufferers more prone to hangover headache Migraine sufferers, beware. You may be more prone to an alcohol-induced headache after a night of drinking, according to researchers from the Jefferson Headache Center. The research will be presented at Neuroscience 2009, the Annual Meeting of the Society for Neuroscience, in Chicago. Study finds partner abuse leads to wide range of health problems Women abused by intimate partners suffer higher rates of a wide variety of doctor-diagnosed medical maladies compared to women who were never abused, according to a new study of more than 3,000 women. A Thermometer for the Earth According to climate change experts, our planet has a fever - melting glaciers are just one stark sign of the radical changes we can expect. Greening university classrooms In today's frenetic world, many urban dwellers spend more than 80% of the day indoors. Bringing nature in to living spaces by enhancing homes and offices with ornamental plants has become another popular facet of the move to "green" our lives. Workplace bullying is associated with sleep disturbances A study in the Sept.1 issue of the journal SLEEP shows that current or past exposure to workplace bullying is associated with increased sleep disturbances. Low-dose estrogen shown safe and effective for metastatic breast cancer When estrogen-lowering drugs no longer control metastatic breast cancer, the opposite strategy might work. Raising estrogen levels benefited 30 percent of women whose metastatic breast cancer no longer responded to standard anti-estrogen treatment. Computer scientists scale 'layer 2' data center networks to 100,000 ports and beyond University of California, San Diego computer scientists have created software that they hope will lead to data centers that logically function as single, plug-and-play networks that will scale to the massive scale of modern data center networks. Children with headache amily quarrels and a lack of free time can promote headaches in children. This is what Jennifer Gassmann and her coauthors concluded in their study on risk factors, which appears in the current issue of the Deutsches Ärzteblatt International. More Headaches Current Events and Headaches News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||